Literature DB >> 16675855

Optimized conditions for measuring lipolysis in murine primary adipocytes.

Srikant Viswanadha1, Constantine Londos.   

Abstract

The current literature on lipolysis in murine primary adipocytes is rife with experiments performed under conditions not optimized for reproducible and reliable results. Here, we present conditions for optimizing the measurement of lipolysis in murine adipocytes. We demonstrate that adenosine management is of paramount importance in evaluating the lipolytic response under basal and stimulated conditions. Also, adipocyte concentrations in the 10,000-15,000 cells per milliliter range produce a greater increase in stimulated lipolysis than higher concentrations, and the response is further enhanced by agitating the cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675855     DOI: 10.1194/jlr.D600005-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  GPR103b functions in the peripheral regulation of adipogenesis.

Authors:  Mukandila Mulumba; Christian Jossart; Riccarda Granata; Davide Gallo; Emanuel Escher; Ezio Ghigo; Marc J Servant; Sylvie Marleau; Huy Ong
Journal:  Mol Endocrinol       Date:  2010-06-09

2.  Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity.

Authors:  Jorge M Caviglia; Jenna L Betters; Dianne-Helerie Dapito; Caleb C Lord; Sean Sullivan; Streamson Chua; Terry Yin; Anna Sekowski; Haiyan Mu; Lawrence Shapiro; J Mark Brown; Dawn L Brasaemle
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

3.  The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice.

Authors:  Jing Lu; Qing Xu; Ming Ji; Xiumei Guo; Xiaojiang Xu; David C Fargo; Xiaoling Li
Journal:  EMBO Rep       Date:  2017-03-31       Impact factor: 8.807

4.  Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue.

Authors:  Ya-Wen Teng; Jessica M Ellis; Rosalind A Coleman; Steven H Zeisel
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

5.  The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.

Authors:  Ryan P Ceddia; DaeKee Lee; Matthew F Maulis; Bethany A Carboneau; David W Threadgill; Greg Poffenberger; Ginger Milne; Kelli L Boyd; Alvin C Powers; Owen P McGuinness; Maureen Gannon; Richard M Breyer
Journal:  Endocrinology       Date:  2015-10-20       Impact factor: 4.736

6.  Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice.

Authors:  Ri-Yao Yang; Lan Yu; James L Graham; Daniel K Hsu; K C Kent Lloyd; Peter J Havel; Fu-Tong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

7.  Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats.

Authors:  Tulasi R Jinka; Zachary A Carlson; Jeanette T Moore; Kelly L Drew
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

8.  Optimization of Thermolytic Response to A1 Adenosine Receptor Agonists in Rats.

Authors:  Isaac R Bailey; Bernard Laughlin; Lucille A Moore; Lori K Bogren; Zeinab Barati; Kelly L Drew
Journal:  J Pharmacol Exp Ther       Date:  2017-06-26       Impact factor: 4.030

9.  Use of fluorescence microscopy to probe intracellular lipolysis.

Authors:  Emilio P Mottillo; George M Paul; Hsiao-Ping H Moore; James G Granneman
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

10.  AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency.

Authors:  Kathy Jaworski; Maryam Ahmadian; Robin E Duncan; Eszter Sarkadi-Nagy; Krista A Varady; Marc K Hellerstein; Hui-Young Lee; Varman T Samuel; Gerald I Shulman; Kee-Hong Kim; Sarah de Val; Chulho Kang; Hei Sook Sul
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.